Jaborandi and Ear neoplasm malignant - from FDA reports
There is no Ear neoplasm malignant reported by people who take Jaborandi yet. This review analyzes which people have Ear neoplasm malignant with Jaborandi. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Dec, 12, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Ear neoplasm malignant when taking Jaborandi?
- Check symptoms - is ear neoplasm malignant caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsEar neoplasm malignant and drugs with ingredients of jaborandi.
Expand the study to include reports from both FDA and eHealthMeEar neoplasm malignant and Jaborandi from FDA and eHealthMe reports
Jaborandi has active ingredients of jaborandi. (latest outcomes from Jaborandi 1 users)
Ear Neoplasm Malignant
Ear neoplasm malignant (ear cancerous tumour) has been reported by people with rheumatoid arthritis, multiple sclerosis, atrial fibrillation/flutter, type 2 diabetes, polychondritis (latest reports from 76 Ear neoplasm malignant patients).